FDC Limited
FDC Limited is an Indian listed company in the Pharmaceuticals & Biotechnology industry (Healthcare sector), traded under NSE: FDC and BSE: 531599 (ISIN INE258B01022).
It has a market capitalisation of ₹5,592 crore, a last close of ₹343.45 on 2026-10-19, a one-year return of -21.5%.
Valuation: a price-to-earnings ratio of 19.11x, a price-to-book ratio of 2.25x, a dividend yield of 1.5%.
Profitability: return on equity of 11.8%, return on capital employed of 15.5%, an operating margin of 15.3%.
Growth: sales growth of 6.8% a year over three years, net profit growth of 13.2% a year over three years.
Balance sheet and ownership: debt-to-equity of 0.00x, promoter holding of 69.7%.
| Metric | Value |
|---|---|
| Market capitalisation | 5,592 |
| Last close | ₹343.45 |
| P/E (TTM) | 19.11x |
| P/B | 2.25x |
| Dividend yield | 1.5% |
| ROE (FY) | 11.8% |
| ROCE (FY) | 15.5% |
| Operating margin (TTM) | 15.3% |
| Sales growth, 3-year CAGR | 6.8% |
| Profit growth, 3-year CAGR | 13.2% |
| Debt / equity | 0.00x |
| Promoter holding | 69.7% |
| 1-year return | -21.5% |
Loading the live page with the price chart, financial history, shareholding and recent filings. Data is end-of-day and rebuilt nightly; nothing here is investment advice. Financial statements · What each metric means